
Publication
Government of Alberta launches nuclear energy engagement
On August 25, 2025, the Government of Alberta publicly re-affirmed its interest in nuclear energy with the launch of its Nuclear Energy Engagement (the Engagement).
Global | Publication | April 2018
The race is on to finalise “level II” implementing measures in time for when the new securitisation framework applies on January 1, 2019.
On January 1, 2019 a new framework for European securitisations will take effect. Two Regulations, which came into force on January 17, 2018, will apply:
Together, this legislative package represents a major milestone in the EU’s Capital Markets Union (CMU) reform agenda. What next? To help you prepare for the deadline, the ten most important points are examined in detail, below.
Publication
On August 25, 2025, the Government of Alberta publicly re-affirmed its interest in nuclear energy with the launch of its Nuclear Energy Engagement (the Engagement).
Publication
Health Canada has proposed a major change to the regulation of biosimilar drugs that may accelerate biologic patent litigation in Canada. Following the lead of other jurisdictions, Health Canada has proposed that biosimilar manufacturers no longer be required to conduct phase 3 clinical trials to enter the Canadian market.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025